SCHEMBL6628274

SCHEMBL6628274

Cc1ccc(N2CCCCC2C)nc1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMPD3 Q9NY59 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ PDPK1 O15530 1/20 0.45
▸ TGFBR1 P36897 1/20 0.45
▸ AURKB Q96GD4 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CHRM4 P08173 4/20 0.43
▸ BCHE P06276 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ SMARCA2 P51531 4/20 0.41
▸ SMARCA4 P51532 4/20 0.41
▸ PBRM1 Q86U86 4/20 0.41
▸ NR1I2 O75469 3/20 0.41
▸ NR1H3 Q13133 2/20 0.41
▸ NR1H2 P55055 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14890430 0.77 ASIC3 (0.49) SMPD3KDM4EMAPTL3MBTL1PDPK1
SCHEMBL25481443 0.75 HRH3 (0.50) SMPD3KDM4EMAPTL3MBTL1PDPK1
SCHEMBL25481828 0.75 HRH3 (0.50) SMPD3KDM4EMAPTL3MBTL1PDPK1
SCHEMBL25481832 0.75 HRH3 (0.50) SMPD3KDM4EMAPTL3MBTL1PDPK1
SCHEMBL27099909 0.74 GFER (0.47) SMPD3KDM4EMAPTL3MBTL1PDPK1
SCHEMBL27093613 0.74 GFER (0.47) SMPD3KDM4EMAPTL3MBTL1PDPK1
SCHEMBL6628400 0.73 MAPT (0.45) SMPD3KDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL27947668 0.73 BCHE (0.56) KDM4EMAPTL3MBTL1ALDH1A1CHRM4
SCHEMBL14120128 0.72 SMPD3 (0.53) SMPD3KDM4EMAPTL3MBTL1BCHE
SCHEMBL14890848 0.72 SMPD3 (0.53) SMPD3KDM4EMAPTL3MBTL1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1483263-A1 THIAZOLYL UREA COMPOUNDS FOR THE TREATMENT OF CANCER Amgen Inc. (US) 2004-12-08 — — EP disclosed
WO-2003070727-A1 THIAZOLYL UREA COMPOUNDS FOR THE TREATMENT OF CANCER AMGEN INC. (US) 2003-08-28 — — WO disclosed
EP-1309589-A2 UREA COMPOUNDS AND METHODS OF USES Amgen Inc. (US) 2003-05-14 — — EP disclosed
WO-2002014311-A2 UREA COMPOUNDS AND METHODS OF USES AMGEN INC. (US) 2002-02-21 — — WO disclosed
Send feedback